Please use this identifier to cite or link to this item: doi:10.22028/D291-44377
Title: Required minimal protein domain of flower for synaptobrevin2 endocytosis in cytotoxic T cells
Author(s): Ravichandran, Keerthana
Schirra, Claudia
Urbansky, Katja
Tu, Szu-Min
Alawar, Nadia
Mannebach, Stefanie
Krause, Elmar
Stevens, David
Lancaster, C. Roy D.
Flockerzi, Veit
Rettig, Jens
Chang, Hsin-Fang
Becherer, Ute
Language: English
Title: Cellular and Molecular Life Sciences
Volume: 82 (2025)
Issue: 1
Publisher/Platform: Springer Nature
Year of Publication: 2024
Free key words: CACFD1
Endocytosis
Lytic granule
CD8+lymphocyte
Immunological synapse
DDC notations: 610 Medicine and health
Publikation type: Journal Article
Abstract: Flower, a highly conserved protein, crucial for endocytosis and cellular ftness, has been implicated in cytotoxic T lymphocyte (CTL) killing efciency through its role in cytotoxic granule (CG) endocytosis at the immune synapse (IS). This study explores the molecular cues that govern Flower-mediated CG endocytosis by analyzing uptake of Synaptobrevin2, a protein specifc to CG in mouse CTL. Using immunogold electron microscopy and total internal fuorescence microscopy, we found that Flower translocates in a stimulus-dependent manner from small vesicles to the IS, thereby ensuring specifcity in CG membrane protein recycling. Using confocal live-cell imaging, we assessed the ability of a range of naturally occurring mouse, human and Drosophila isoforms to rescue defective endocytosis in Flower KO CTLs. This analysis demonstrated that the N-terminal portion of the protein, encompassing amino acids 1–106 in mice, is the minimal domain necessary for Synaptobrevin2 endocytosis. Additionally, we identifed two pivotal sites through site-specifc mutation: a putative AP2- binding site, and a tyrosine at position 104 in mouse Flower. These fndings provide insights into Flower's specifc functional domain essential for CG endocytosis, which is a key process in mediating T cell serial killing required for the efective fght against cancer.
DOI of the first publication: 10.1007/s00018-024-05528-1
URL of the first publication: https://link.springer.com/article/10.1007/s00018-024-05528-1
Link to this record: urn:nbn:de:bsz:291--ds-443778
hdl:20.500.11880/39645
http://dx.doi.org/10.22028/D291-44377
ISSN: 1420-9071
Date of registration: 13-Feb-2025
Description of the related object: Supplementary Information
Related object: https://static-content.springer.com/esm/art%3A10.1007%2Fs00018-024-05528-1/MediaObjects/18_2024_5528_MOESM1_ESM.pdf
Faculty: M - Medizinische Fakultät
Department: M - Biophysik
M - Experimentelle und Klinische Pharmakologie und Toxikologie
M - Physiologie
Professorship: M - Prof. Dr. Veit Flockerzi
M - Prof. Dr. C. Roy D. Lancaster
M - Prof. Dr. Jens Rettig
Collections:SciDok - Der Wissenschaftsserver der Universität des Saarlandes

Files for this record:
File Description SizeFormat 
s00018-024-05528-1.pdf2,67 MBAdobe PDFView/Open


This item is licensed under a Creative Commons License Creative Commons